Skip to main content
Stephen Smith, MD, Ophthalmology, Stanford, CA

StephenSmithMD

Ophthalmology Stanford, CA

Retinal Disease

Physician

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Surgical Retina and Vitreous, 2016 - 2018
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Ophthalmology, 2013 - 2016
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 2012
  • Grove City College
    Grove City CollegeB.S., Molecular Biology, Magna cum Laude, 2003 - 2006
  • University of Miami
    University of MiamiNo degree, 2002

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2013 - 2027
  • CA State Medical License
    CA State Medical License 2016 - 2026
  • FL State Medical License
    FL State Medical License 2021 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • The George Slocum Resident Research Award – 1st Place University of Michigan, 2015
  • Walter R. Parker Resident Teaching Award – 3rd Place University of Michigan, 2015
  • Aizman Award University of Michigan, 2016
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Preclinical acute ocular safety study of combined intravitreal carboplatin and etoposide phosphate for retinoblastoma  
    Mohney BG, Elner V, Smith AB, Harbour JW, Smith BD, Smith SJ, Ophthalmic Surg Lasers Imaging Retina, 1/1/2017
  • Ocular side effects following intravitreal injection therapy for retinoblastoma: A systematic review  
    Smith SJ, Smith BD, Mohney BG, Br J Ophthalmol, 1/1/2014
  • Quantifying diplopia with a questionnaire  
    Holmes JM, Liebermann L, Hatt SR, Smith SJ, Leske DA, Ophthalmology, 1/1/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Preclinical acute safety study of combined intravitreal carboplatin and etoposide phosphate for retinoblastoma with vitreous seeding
    Smith SJ, Grossniklaus H, Mruthyunjaya P, Smith BD, Smith AS, Mohney BG, Musch D, The Retina Society Annual Meeting, Paris, France, 2015; Boston, MA, 2017, 1/7/2017
  • Ocular Toxicity of Intravitreal Melphalan for Retinoblastoma
    Smith SJ, Smith BD, Association for Research in Vision and Ophthalmology Annual Meeting, Denver, CO, 1/3/2015
  • Maculopathy in patients with monoclonal gammopathy of undetermined significance
    Smith SJ, Johnson JM, The Association for Research in Vision and Ophthalmology Annual Meeting, Ft. Lauderdale, FL, 1/8/2014
  • Join now to see all

Lectures

  • Retinal Vein Occlusion: Basic principles and new clinical insights 
    Palo Alto, CA - 1/10/2017
  • Acute pre-clinical ocular safety study of combined intravitreal carboplatin and etoposide phosphate for retinoblastoma 
    Mackinac Island, MI - 1/8/2015
  • Fine Needle Aspiration Biopsy (FNAB) for Retinoblastoma: Indications and Contraindications 
    Orlando, FL - 1/3/2014
  • Join now to see all

Other

  • Diabetic retinopathy: halting and reversing progression. The second of three parts 
    Smith SJ, Greven MA, Mruthyunjaya P, Retinal Physician
    1/1/2017
  • Halting and reversing DR progression with anti-VEGF: clinical and economic relevance. The third of a three-part series 
    Smith SJ, Greven MA, Mruthyunjaya P, Retinal Physician
    1/1/2017
  • Current concepts in diagnosis and management of central retinal artery occlusion 
    Greven MA, Smith SJ, Retinal Physician
    1/1/2016
  • Join now to see all